Results 61 to 70 of about 3,401,781 (173)
Supplementary Figure S5 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S5. Overview of GO Biological process pathways found enriched in A. CD4+ T cells (6 hrs), B. CD8+ T cells (6 hrs), C. monocytes (6 hrs) and D. neutrophils (4 hrs) after treatment with 0.2 μg/mL CD20-TCB.</p>Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceSupplementary Figure S10 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S10. Single cell RNA-sequencing of whole blood treated with 0.2 μg/mL CD20-TCB was performed using the BD Rhapsody platform</p>Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceSupplementary Figure S2 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S2. Proportions of T cells, monocytes and neutrophils in human whole blood after treatment with 0.2 μg/mL CD20-TCB</p>Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceSupplementary Figure S4 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S4. Multidimensional scaling plot of gene expression distances between pseudobulks</p>Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceSupplementary Figure S3 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S3. Identification of an interacting B and T cells cluster by scRNA sequencing of human whole blood treated with 0.2 μg/mL CD20-TCB using the BD Rhapsody platform.</p>Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceCytokine release syndrome
Journal of Pediatric Critical CareCytokine release syndrome (CRS) is a severe, potentially life-threatening immune-mediated condition characterized by excessive cytokine secretion leading to systemic inflammation and multiorgan dysfunction.Rachit Mehta, Indira Jayakumardoaj +1 more sourceSupplementary Figure S12 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
, 2023 <p>Supplementary Figure S12. Individual tumor growth curves for each treatment group. OCI-Ly18 (DLBCL)-bearing humanized NSG mice were pre-treated with 30 mg/kg Gazyva (Gpt, grey arrow) and treated weekly with escalating doses of CD20-TCB (0.5 mg/kg, 1 mg/kg, 2 mg/kg, red arrows).Marina Bacac, Pablo Umaña, Christian Klein, Hélène Haegel, Katerina Apostolopoulou, Floriana Cremasco, Marlene Biehl, Roberta Bianchi, Sylvia Jenni, Stefanie Briner, Johannes Sam, Petra Schwalie, Petra Gerber, Stephan Schmeing, Sylvia Herter, Tamara Hüsser, Emilio Yángüez, Emily Piccione, Sabrina Danilin, Sina Nassiri, Llucia Albertí Servera, Nathalie Steinhoff, Gabrielle Leclercq-Cohen +22 moreopenaire +1 more sourceNeutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
Nature CommunicationsCytokine release syndrome (CRS) is the most common complication of chimeric antigen receptor redirected T cells (CAR-T) therapy. CAR-T toxicity management has been greatly improved, but CRS remains a prime safety concern.Shuangshuang Yang, Jie Xu, Yuting Dai, Shiwei Jin, Yan Sun, Jianfeng Li, Chenglin Liu, Xiaolin Ma, Zhu Chen, Lijuan Chen, Jian Hou, Jian-Qing Mi, Sai-Juan Chen +12 moredoaj +1 more source